Christopher L. Jacobs is a United States Representative from NY affiliated with the Republican Party, serving in the US House of Representatives. Disclosed Capitol tracks 255 disclosed stock trades from Christopher L. Jacobs, filed under the STOCK Act. The portfolio compounds at 1.9% annualized — 3.5% below the S&P 500 benchmark over the same period, with a 53% win rate on individual trades. The full trade history, holdings, sector allocation, and risk metrics are below.
| Description | Ticker | Buy/Sell | Trade Date |
|---|---|---|---|
| Anavex Life Sciences Corp. | AVXL | SELL | Dec 12, 2022 |
| Archrock, Inc. | AROC | BUY | Dec 12, 2022 |
| Athira Pharma, Inc. | ATHA | BUY | Dec 12, 2022 |
| Bank of America Corporation | BAC | SELL | Dec 12, 2022 |
| Berkshire Hathaway Inc. New | BRK-B | BUY | Dec 12, 2022 |
| BioLife Solutions, Inc. | BLFS | SELL | Dec 12, 2022 |
| Brigham Minerals, Inc. Class | MNRL | BUY | Dec 12, 2022 |
| Cassava Sciences, Inc. | SAVA | BUY | Dec 12, 2022 |
| Chevron Corporation | CVX | SELL | Dec 12, 2022 |
| Chord Energy Corporation | CHRD | BUY | Dec 12, 2022 |